Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 996-1003

  Sokolović, Aleksandar ^a   Montenegro Miranda, Paula S ^a   de Waart, Dirk Rudi ^a   Cappai, Radha M N ^a   Duijst, Suzanne ^a   Sokolović, Milka ^a   Bosma, Piter J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

AAV; Abcb4 mice; IGFBP5; Inflammation; Liver fibrosis; Systems genetics

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; GREEN FLUORESCENT PROTEIN; SOMATOMEDIN BINDING PROTEIN 5;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE COMPOSITION; BILE DUCT DISEASE; BLOOD ANALYSIS; CELL DAMAGE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HISTOPATHOLOGY; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; STELLATE CELL;

ANIMALS; BILE DUCTS, INTRAHEPATIC; CELL PROLIFERATION; COLLAGEN; EXTRACELLULAR MATRIX; GREEN FLUORESCENT PROTEINS; HEPATIC STELLATE CELLS; HEPATOCYTES; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; P-GLYCOPROTEINS; TRANSCRIPTION, GENETIC;

MUS;

EID: 84859070068     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.022     Document Type: Article

References (39)

1. Jacquemin E., de Vree J.M., Cresteil D., Sokal E.M., Sturm E., Dumont M., Scheffer G.L., Paul M., Burdelski M., Bosma P.J., Bernard O., Hadchouel M., Elferink R.P. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001, 120:1448-1458.
2. Katzenellenbogen M., Pappo O., Barash H., Klopstock N., Mizrahi L., Olam D., Jacob-Hirsch J., Amariglio N., Rechavi G., Mitchell L.A., Kohen R., Domany E., Galun E., Goldenberg D. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice. Cancer Res. 2006, 66:4001-4010.
3. Mauad T.H., van Nieuwkerk C.M., Dingemans K.P., Smit J.J., Schinkel A.H., Notenboom R.G., van den Bergh Weerman M.A., Verkruisen R.P., Groen A.K., Oude Elferink R.P. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 1994, 145:1237-1245.
4. Benyon R.C., Arthur M.J. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 2001, 21:373-384.
5. Gatti D., Maki A., Chesler E.J., Kirova R., Kosyk O., Lu L., Manly K.F., Williams R.W., Perkins A., Langston M.A., Threadgill D.W., Rusyn I. Genome-level analysis of genetic regulation of liver gene expression networks. Hepatology 2007, 46:548-557.
6. Schuppan D., Ruehl M., Somasundaram R., Hahn E.G. Matrix as a modulator of hepatic fibrogenesis. Semin. Liver Dis. 2001, 21:351-372.
7. Friedman S.L. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 2004, 1:98-105.
8. Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis. 2004, 36:231-242.
9. Boers W., Aarrass S., Linthorst C., Pinzani M., Elferink R.O., Bosma P. Transcriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor-binding proteins. J. Biol. Chem. 2006, 281:16289-16295.
10. Nishino R., Honda M., Yamashita T., Takatori H., Minato H., Zen Y., Sasaki M., Takamura H., Horimoto K., Ohta T., Nakanuma Y., Kaneko S. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J. Hepatol. 2008, 49:207-216.
11. Sokolovic A., Sokolovic M., Boers W., Elferink R.P., Bosma P.J. Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells. Fibrogenesis Tissue Repair 2010, 3:3.
12. Pilewski J.M., Liu L., Henry A.C., Knauer A.V., Feghali-Bostwick C.A. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 2005, 166:399-407.
13. Yasuoka H., Jukic D.M., Zhou Z., Choi A.M., Feghali-Bostwick C.A. Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis Rheum. 2006, 54:3001-3010.
14. Clemmons D.R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 1997, 8:45-62.
15. Nathwani A.C., Gray J.T., Ng C.Y., Zhou J., Spence Y., Waddington S.N., Tuddenham E.G., Kemball-Cook G., McIntosh J., Boon-Spijker M., Mertens K., Davidoff A.M. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 2006, 107:2653-2661.
16. Seppen J., Bakker C., de Jong B., Kunne C., van den Oever K., Vandenberghe K., de Waart R., Twisk J., Bosma P. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Mol. Ther. 2006, 13:1085-1092.
17. van Westrhenen R., de Waart D.R., Akman S., Krediet R.T. Assessment of peritoneal fibrosis by conventional light microscopy and hydroxyproline measurements. Perit. Dial. Int. 2004, 24:290-292.
18. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969, 27:502-522.
19. Sokolovic M., Wehkamp D., Sokolovic A., Vermeulen J., Gilhuijs-Pederson L.A., van Haaften R.I., Nikolsky Y., Evelo C.T., van Kampen A.H., Hakvoort T.B., Lamers W.H. Fasting induces a biphasic adaptive metabolic response in murine small intestine. BMC Genomics 2007, 8:361.
20. Geisert E.E., Lu L., Freeman-Anderson N.E., Templeton J.P., Nassr M., Wang X., Gu W., Jiao Y., Williams R.W. Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice. Mol. Vis. 2009, 15:1730-1763.
21. Grimm D., Pandey K., Nakai H., Storm T.A., Kay M.A. Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J. Virol. 2006, 80:426-439.
22. van Nieuwkerk C.M., Elferink R.P., Groen A.K., Ottenhoff R., Tytgat G.N., Dingemans K.P., van den Bergh Weerman M.A., Offerhaus G.J. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996, 111:165-171.
23. Kershenobich S.D., Weissbrod A.B. Liver fibrosis and inflammation. A review. Ann. Hepatol. 2003, 2:159-163.
24. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
25. Argmann C.A., Chambon P., Auwerx J. Mouse phenogenomics: the fast track to "systems metabolism". Cell Metab. 2005, 2:349-360.
26. Chesler E.J., Lu L., Shou S., Qu Y., Gu J., Wang J., Hsu H.C., Mountz J.D., Baldwin N.E., Langston M.A., Threadgill D.W., Manly K.F., Williams R.W. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat. Genet. 2005, 37:233-242.
27. Koutnikova H., Laakso M., Lu L., Combe R., Paananen J., Kuulasmaa T., Kuusisto J., Haring H.U., Hansen T., Pedersen O., Smith U., Hanefeld M., Williams R.W., Auwerx J. Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genet. 2009, 5:e1000591.
28. Tonner E., Barber M.C., Travers M.T., Logan A., Flint D.J. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 1997, 138:5101-5107.
29. Thomas L.N., Cohen P., Douglas R.C., Lazier C., Rittmaster R.S. Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats. Prostate 1998, 35:273-278.
30. Meadows K.A., Holly J.M., Stewart C.E. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J. Cell. Physiol. 2000, 183:330-337.
31. Novo E., Busletta C., di Bonzo L.V., Povero D., Paternostro C., Mareschi K., Ferrero I., David E., Bertolani C., Caligiuri A., Cannito S., Tamagno E., Compagnone A., Colombatto S., Marra F., Fagioli F., Pinzani M., Parola M. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J. Hepatol. 2011, 54(5):964-974.
32. Greenwel P., Dominguez-Rosales J.A., Mavi G., Rivas-Estilla A.M., Rojkind M. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 2000, 31:109-116.
33. Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology 2006, 44:1487-1501.
34. Bataller R., Sancho-Bru P., Gines P., Brenner D.A. Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid. Redox Signal. 2005, 7:1346-1355.
35. Novo E., Marra F., Zamara E., Valfre di B.L., Caligiuri A., Cannito S., Antonaci C., Colombatto S., Pinzani M., Parola M. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 2006, 55:90-97.
36. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 2004, 40:60-68.
37. Cazzalini O., Perucca P., Savio M., Necchi D., Bianchi L., Stivala L.A., Ducommun B., Scovassi A.I., Prosperi E. Interaction of p21(CDKN1A) with PCNA regulates the histone acetyltransferase activity of p300 in nucleotide excision repair. Nucleic Acids Res. 2008, 36:1713-1722.
38. Zhao B., Benson E.K., Qiao R., Wang X., Kim S., Manfredi J.J., Lee S.W., Aaronson S.A. Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice. EMBO Rep. 2009, 10:71-78.
39. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S.W. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.